Skip to content
Patients
HCPs
X-twitter Instagram Youtube Icon-mail Tiktok
Follow on X
Home
Daily Updates

Categories

Antiviral prophylaxis for hepatitis B virus reactivation in T-cell lymphoma patients with resolved hepatitis B virus infection.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This retrospective study evaluated the impact of anti-HBV prophylaxis on HBV reactivation in T-cell lymphoma (TCL) patie...

Continue ReadingAntiviral prophylaxis for hepatitis B virus reactivation in T-cell lymphoma patients with resolved hepatitis B virus infection.

Update in the Management of ACTH-Secreting Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

ACTH-secreting neuroendocrine neoplasms (NENs) are rare but often severe tumors with poor prognosis if not properly mana...

Continue ReadingUpdate in the Management of ACTH-Secreting Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms.

Pirtobrutinib in the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

Pirtobrutinib is a novel noncovalent BTK inhibitor designed to overcome resistance caused by BTK mutations, particularly...

Continue ReadingPirtobrutinib in the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma.

Author Correction: In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

The publication presents a study focused on advancing cancer treatment through a novel therapeutic approach. It details...

Continue ReadingAuthor Correction: In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions.

Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This study investigates the cancer risk associated with germline monoallelic pathogenic variants (PVs) in DDX41, which p...

Continue ReadingMyeloid neoplasms risks for germline DDX41 pathogenic variants carriers.

IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This study evaluated genetic markers predicting response to erythropoiesis-stimulating agents (ESAs) in lower-risk myelo...

Continue ReadingIPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score.
  • © Together4Cancer. All rights reserved.
  • Privacy Policy
  • Terms of Use